Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RJ017
- Development stage
- Preclinical
- Lead developer
- Risen Medical Technology
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
RJ017 is an antisense oligonucleotide (ASO) currently in preclinical development by Risen Shanghai Medical Technology (Risen Pharma). It is being investigated for the treatment of autoimmune diseases. As an antisense therapy, RJ017 is designed to bind to a specific messenger RNA (mRNA) sequence to modulate the expression of a target protein involved in the pathogenesis of autoimmune conditions. While the specific molecular target remains undisclosed by the developer, the drug represents part of Risen Pharma's expanding portfolio of oligonucleotide-based therapies targeting immunological and metabolic disorders.
Beyond the preview
Go deeper on RJ017.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RJ017.